Table 3.

Multivariate analysis of a 30-day permanent pacemaker (PM) implantation after transcatheter aortic valve implantation (TAVI).

Variables	OR (95% CI)	p Value
Male sex	0.80 (0.68–0.93)	<0.01
Age (years)	1.01 (1.00–1.02)	0.08
Weight (kg)	1.00 (1.00–1.01)	0.10
Creatinine serum level (for 100 μmol/L)	1.15 (1.01–1.31)	0.04
Diabetes mellitus	1.04 (0.88–1.22)	0.65
Left ventricular ejection fraction (%)	1.00 (1.00–1.01)	0.43
Systolic pulmonary pressure (mmHg)	1.00 (1.00–1.01)	0.51
History of lung disease	1.00 (0.84–1.19)	0.97
Peripheral vascular disease	0.98 (0.81–1.19)	0.87
Previous cardiac surgery	0.95 (0.74–1.20)	0.64
Recent myocardial infarction	0.80 (0.46–1.41)	0.44
Dialysis	0.84 (0.38–1.88)	0.67
Euroscore II (%)	1.00 (0.98–1.02)	0.96
Previous aortic valve surgery	0.42 (0.26–0.69)	<0.01
Transfemoral TAVI access	1.34 (1.11–1.61)	<0.01
Pre-dilatation valve	0.90 (0.78–1.03)	0.14
Post-dilatation valve	1.58 (1.33–1.89)	<0.01

OR = odds ratio; CI = confidence interval; TAVI = transcatheter aortic valve implantation.